A large-scale randomized controlled trial from Costa Rica finds that one dose of either a bivalent (two-strain) or nonavalent (nine-strain) human papillomavirus (HPV) vaccine provides the same protection against infection with the HPV16 or HPV18…
Single HPV vaccine dose matches protection of 2-dose regimen, new trial shows
